DOI: http://dx.doi.org/10.18203/2349-2902.isj20210372

Role of centchroman versus danazol in treatment of benign breast disorders

Hanuman Ram Khoja, Bodu Ram Barala, Saurabh Sharma, Prabha Om, Devendra Saini

Abstract


Background: The breast is a dynamic structure that undergoes cyclical changes throughout the menstrual cycle. Any aberration from normal physiological changes in breast produces different problem in breast. Many drugs are used for treatment for these disorders like Danazol, Bromocriptine, Tamoxifen and LH-RH analogue but still no consensus for any drug is present.

Methods: The aim of our study was to analyze the effectiveness of drug Centchroman and its comparison with Danazol in treatment of benign breast disorders in respect to symptoms relief, decrease in nodularity and lump size, recurrence, cost and side effects of drug. This prospective study was conducted on 250 patients of benign breast disorders attending surgical OPD between May 2018 to September 2019 in SMS medical college and Hospital, Jaipur.

Results: Tolerance and improvements in symptoms in centchroman group was more than danazol (100% vs 92.8%) with less recurrence in former group. While side effects varied between the two groups with menstrual irregularities more common in centchroman group.

Conclusions: The study shows that centchroman is safe, more effective and less expensive to Danazol for the treatment of benign breast disorders in long term.


Keywords


Benign breast disorder, Breast pain, Breast lump, Centchroman, Danazol

Full Text:

PDF

References


Tejwani PL, Srivastava A, Nerkar H, Dhar A, Hari S, Thulkar S, et al. Centchroman regresses mastalgia: a randomized comparison with danazol. Indian J Surg. 2011;73(3):199-205.

Dhar A, Srivastava A. Role of centchroman in regression of mastalgia and fibroadenoma. World J Surg. 2007;31(6):1178-84.

Khanna S. Comparative evaluation of the role of Centchroman in benign breast diseases: Int J Biol Med Res. 2016;7(2):5563-8.

Greenblatt RB, Dmowski WP, Mahesh VB, Scholer HFL. Clinical studies with an antigonadotropin-danazol. Fertil Steril. 22:102,1971

Pye J, Mansel R, Hughes L. Clinical experience of drug treatments for mastalgia. The Lancet. 1985;326(8451):373-7.

Gateley C, Mansel, R. Management of the painful and nodular breast. British Medical Bulletin. 1991;47(2):284-94.

Ortiz-Mendoza CM, Olvera-Mancilla M. Danazol effectively in control of moderate to severe mastalgia. Cir. 2004;72(6):479-82.